Drug costs rising fast in Canadian health-care spending, report finds
More expensive "biologic" treatments and the end of a period when Canadians saw cost savings as patents expired and generics flooded the market driving growth in pharmaceutical prices, experts say.
Aucun commentaire:
Enregistrer un commentaire